Mergers & Acquisitions ·
Enovis Corporation entered into a binding offer to acquire eCential Robotics SAS, a developer of surgical robotics and…
ENOVEnovis Corp
Enovis Corporation entered into a binding offer to acquire eCential Robotics SAS, a developer of surgical robotics and enabling technologies, for an enterprise value of approximately €155 million. The transaction involves upfront cash consideration of roughly €176 million to shareholders, with potential additional contingent payments of up to €35 million upon milestone achievement. Enovis plans to fund the deal using existing cash and its revolving credit facility, expecting closure by year-end 2026 subject to regulatory approvals. The acquisition aims to integrate robotic automation into Enovis' ASTRA platform, though it is expected to cause a 100 basis point headwind to adjusted EBITDA margins in 2027 due to deal-related dilution. Enovis Corporation operates as a global medical technology innovator focused on solutions that enhance patient outcomes and restore motion.